| Neoarteries grown in vivo using a tissue-engineered hyaluronan-based scaffold. | |
| | |
MedLine Citation:
|
PMID: 18385214 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Vascular tissue engineering has emerged as a promising technology for the design of an ideal, responsive, living conduit with properties similar to that of native tissue. The missing link in tissue-engineered blood vessels is elastin biosynthesis. Several biomaterials are currently used but few support elastin biosynthesis in a 3-D array. In previous studies, we demonstrated that a hyaluronan-based scaffold (HYAFF-11) grafted in the infrarenal rat aorta successfully guided the complete regeneration of a well-functioning small-diameter (2 mm) neoartery. The aim of the present study was to test the ability of HYAFF-11 biodegradable grafts to develop into neovessels of larger size (4 mm) in a porcine model, focusing on extracellular matrix (ECM) remodeling and elastin biosynthesis. HYAFF-11 tubes (diameter 4 mm, length 5 cm) were implanted in an end-to-end fashion in the common carotid artery. Grafts were analyzed for patency with a Duplex scan every 15 days. ECM components were evaluated by histological and molecular biological methods. All the animals survived the observation period without complications. Intimal hyperplasia (initiating at the anastomotic site) and graft thrombosis led to 3 cases of partial or complete occlusion, as demonstrated by histological examination. There were no signs of stenoses or aneurysms in the remaining grafts. After 5 months, the biomaterial was almost completely degraded and replaced by a neoartery segment composed of mature smooth muscle cells, collagen, and elastin fibers organized in layers and was completely covered on the luminal surface by endothelial cells (vWF(+)). Whereas in previous small animal studies, patency rates were not optimal, those obtained in the present study using hyaluronan-based grafts of larger size confirmed the ability of these constructs to guide the development of a well-functioning neoartery, with the remarkable additional attribute of facilitating the formation of organized layers of elastin fibers. |
| | |
Authors:
|
Barbara Zavan; Vincenzo Vindigni; Sandro Lepidi; Ilaria Iacopetti; Giampiero Avruscio; Giovanni Abatangelo; Roberta Cortivo |
Related Documents
:
|
8846174 - Aneurysm formation in modified human umbilical vein grafts. 17670604 - In situ bilateral skeletonized internal thoracic arterial grafting for left-side myocar... 11331834 - Intraoperative superficial femoral artery balloon angioplasty and popliteal to distal b... 14988894 - Gastroepiploic artery graft angiography via brachial approach using a yumiko catheter. 8850564 - Cardiac neural crest is essential for the persistence rather than the formation of an a... 7707574 - Mycotic aneurysm of the left subclavian artery presented with hemoptysis in an immunosu... |
Publication Detail:
|
Type: Journal Article Date: 2008-04-02 |
Journal Detail:
|
Title: FASEB journal : official publication of the Federation of American Societies for Experimental Biology Volume: 22 ISSN: 1530-6860 ISO Abbreviation: FASEB J. Publication Date: 2008 Aug |
Date Detail:
|
Created Date: 2008-08-04 Completed Date: 2008-09-03 Revised Date: 2012-02-15 |
Medline Journal Info:
|
Nlm Unique ID: 8804484 Medline TA: FASEB J Country: United States |
Other Details:
|
Languages: eng Pagination: 2853-61 Citation Subset: IM |
Affiliation:
|
Department of Histology, Microbiology, and Medical Biotechnologies, University of Padova, Via Giustiniani 2, 35100 Padova, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Arterial Occlusive Diseases / etiology, pathology Base Sequence Biocompatible Materials Bioprosthesis* / adverse effects Blood Vessel Prosthesis* / adverse effects Blood Vessel Prosthesis Implantation Carotid Artery, Common / metabolism, pathology, surgery DNA Primers / genetics Elastin / biosynthesis Extracellular Matrix / metabolism Gene Expression Hyaluronic Acid* Materials Testing Sus scrofa Tissue Engineering / methods* |
| Chemical | |
Reg. No./Substance:
|
0/Biocompatible Materials; 0/DNA Primers; 9004-61-9/Hyaluronic Acid; 9007-58-3/Elastin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: B56beta, a regulatory subunit of protein phosphatase 2A, interacts with CALEB/NGC and inhibits CALEB...
Next Document: Analogous oligo-acyl-lysines with distinct antibacterial mechanisms.